Navigation Links
Data From LigoCyte's Clinical Studies of Norovirus VLP Vaccine Presented at 13th Annual Conference on Vaccine Research
Date:4/28/2010

ly brief. No vaccine-related serious adverse events occurred.  

"This is a unique example of a vaccine against an enteric virus that was well tolerated and highly immunogenic when given intranasally. The vaccine activated immune cells with the capacity to migrate to the gastrointestinal tract and produce antibodies that have the potential to prevent infection," said Marcela F. Pasetti, Ph.D., Associate Professor of Pediatrics at the University of Maryland School of Medicine, who presented the data at the Vaccine Research Conference. Dr. Pasetti also is chief of the Applied Immunology Section at the University of Maryland Center for Vaccine Development.

The investigational, nasally delivered, dry powder vaccine is currently being examined in a Phase I/II study designed to assess safety and immunogenicity plus potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo. The company expects to release interim results for this study next quarter. In addition, the company expects to begin a Phase I trial with an intramuscular version of norovirus VLP vaccine before the end of 2010.

About Norovirus Infection

Norovirus infection, well known as the "stomach flu," is the most common cause of acute gastroenteritis, afflicting nearly 23 million Americans annually. Norovirus infection is characterized by the acute onset of nausea, vomiting, abdominal cramps, diarrhea, and occasionally fever. Severe clinical outcomes are associated with at-risk populations, where complications caused by infection can disrupt primary treatment regimens and even lead to death. Noroviruses are highly infective and easily transmitted. Epidemic outbreaks occur in communit
'/>"/>

SOURCE LigoCyte Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioMedix Receives Clinical Approval for TRAKnet Software
2. Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week
3. Suzie Williams, CP Joins Orthocare Innovations as Clinical Services Manager
4. Kristalose(R) Clinical Data to Be Presented at Digestive Disease Week(R) Meeting
5. Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites
6. AFFiRiS AG: Alzheimers Vaccine AD02 Already in Clinical Phase II
7. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
8. PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention
9. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
10. Creating Healthcare Reform from the Inside Out Through Supply Chain Best Practices that Improve Financial and Clinical Performance is Focus of 2010 GHX Supply Chain Summit
11. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Psychemedics Corporation (NASDAQ: PMD ) today announced second ... 2015.  The Company also announced a quarterly dividend of ... of August 7, 2015 to be paid on August ... consecutive quarterly dividend. The Company,s revenue ... million versus $7.7 million for the quarter ended June ...
(Date:7/28/2015)... July 28, 2015  Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment ... the SENZA-RCT results in the Online First edition ... American Society of Anesthesiologists. The ... was the first to directly compare spinal cord ...
(Date:7/28/2015)... OKLAHOMA CITY , July 28, 2015 /PRNewswire/ ... PDRX) today announced that it has partnered with ... their Infrastructure as a Service (IaaS) product. ... to medical practices across the United States.  Using ... improve disaster recovery and business continuity, ensure regulatory ...
Breaking Medicine Technology:Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2PD-Rx Partners With Dobson Technologies 2
... Bionovo, Inc. (Nasdaq: BNVI ) announced today that ... fiscal year 2009 ended September 30, 2009 on Thursday, November ... web cast to review the financial results on Thursday, November ... access the call by dialing (800) 860-2442 or (412) 858-4600, ...
... AMSTERDAM, October 29 Amsterdam Molecular,Therapeutics ... entered into a development and commercialization agreement for,LPLchip(TM), a ... lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as,a ... In June of this year AMT ...
Cached Medicine Technology:AMT Starts Development LPLChip(TM) With Progenika 2AMT Starts Development LPLChip(TM) With Progenika 3
(Date:7/28/2015)... , ... July 28, 2015 , ... Healthline , ... a recent survey (1) examining consumers’ perspectives on digital health . The ... covered topics such as innovations in digital health, level of trust in the security ...
(Date:7/28/2015)... ... July 28, 2015 , ... Women in Technology (WIT), the premier organization contributing ... 20 years, has selected Lisa Dezzutti, CEO and president at Market Connections, Inc. as ... to serve this organization that empowers women to thrive and excel in the technology ...
(Date:7/28/2015)... ... 28, 2015 , ... Master flutist and solo artist Gary Stroutsos shares his ... in this collection of serene, restorative instrumental music. Tracks carefully curated by White ... body work and more -- to help the listener deeply breathe in a healing ...
(Date:7/28/2015)... ... 2015 , ... Healthpointe ’s Cosmetic Laser Institute in Anaheim is now ... and reduces the appearance of fine lines and wrinkles. , According to the Allergan ... add volume to your cheek area to correct age-related volume loss in adults over ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... On July ... officials refused to schedule the hearing of proposed bills and laws revolving the implementation ... new infections to date. Some vigilante ministers are continuing to hand out clean needles ...
Breaking Medicine News(10 mins):Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 3Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 4Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3
... was diagnosed with lung cancer has won $ 1 million in ... suffering from an inoperable lung cancer. ,Doctors have given ... At this juncture, he has won this lottery. But the irony ... paid $50,000 in annual installments over twenty years. ,Schenk ...
... University in Chicago claim that men who have undergone ... type// of dementia. This study was published in Cognitive ... on 106 men. Out of this, 25 developed a ... undergone vasectomy. According to the chief scientist of this ...
... new study suggests that patients who develop Parkinson's ... history includes alcohol// abuse may be more likely ... of medications used to treat their condition. ... hypersexuality, binge eating and pathological gambling—have been associated ...
... People who have multiple sclerosis (MS) for 10 years and have ... they// have “benign MS” and that their symptoms will likely not ... A new study shows that unfortunately this may not be correct. ... nearly half of those whose MS was benign at 10 years, ...
... Medicare coverage for colorectal cancer screening has increased, there ... a report published recently, some of these disparities are ... ,Colorectal cancer is the third most common ... with approximately 145,290 new cases in 2005, according to ...
... test that can distinguish between a pair of nearly ... treatment. ,Their report is published this week ... the National Academy of Sciences. ,"This simple ... quickly implemented in the clinic to benefit patients by ...
Cached Medicine News:Health News:Compulsive Gambling Linked to Parkinson's Disease Medications 2Health News:Disparities in Colon Cancer Screening Remain Among Medicare Patients 2Health News:A New Two-gene Test to Discern Similar Gastrointestinal Cancers 2
This is adapted to microplate or card....
ScanGel® Incubator...
... The ID-Micro Typing System™ ... for a broad range of ... include antibody screening and identification, ... phenotyping, compatibility testing, reverse serum ...
... 120 Mini-Vertical Gel System simplifies the process of ... format. It is able to run four gels ... To maximize utility and throughput, the 120 mini-vertical ... gels (W x L) at one time. The ...
Medicine Products: